| 000 | 01605 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517043316.0 | ||
| 264 | 0 | _c20160811 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1573-904X | ||
| 024 | 7 |
_a10.1007/s11095-015-1752-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrill, Margreke J | |
| 245 | 0 | 0 |
_aThe Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cDec 2015 |
||
| 300 |
_a3927-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBariatric Surgery |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMidazolam _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity, Morbid _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _avan Rongen, Anne | |
| 700 | 1 | _avan Dongen, Eric P | |
| 700 | 1 | _avan Ramshorst, Bert | |
| 700 | 1 | _aHazebroek, Eric J | |
| 700 | 1 | _aDarwich, Adam S | |
| 700 | 1 | _aRostami-Hodjegan, Amin | |
| 700 | 1 | _aKnibbe, Catherijne A | |
| 773 | 0 |
_tPharmaceutical research _gvol. 32 _gno. 12 _gp. 3927-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11095-015-1752-9 _zAvailable from publisher's website |
| 999 |
_c25101130 _d25101130 |
||